Proteintech Appoints Patrick Yount as CFO and Promotes Jeb Gaybrick to Lead Corporate Strategy and Investor Relations Proteintech Group, Inc., a global life sciences company, has announced two leadership changes aimed at supporting its continued growth and preparing the organization…
Bausch + Lomb Appoints Thomas J. Appio as Interim CEO as Brent Saunders Departs Bausch + Lomb Corporation, a leading global eye health company, and its parent company, Bausch Health Companies Inc. (NYSE/TSX: BHC), have announced the appointment of Thomas…
Genentech’s Tecentriq Receives FDA Approval for Adjuvant Treatment of Stage III dMMR Colon Cancer Genentech, a member of the Roche Group (SIX: RO, ROP; OTCQX: RHHBY), announced that the U.S. Food and Drug Administration (FDA) has approved Tecentriq® (atezolizumab) and…
FDA Approves Pfizer’s TUKYSA Regimen for First-Line Maintenance in HER2+ Metastatic Breast Cancer Pfizer Inc. announced that the U.S. Food and Drug Administration (FDA) has approved TUKYSA® (tucatinib) in combination with trastuzumab and pertuzumab for the maintenance treatment of adults…
City of Hope Names Laurie Sicaeros and Melissa Childress to Lead Cancer Centers in Arizona and Atlanta City of Hope, one of the largest and most advanced cancer research and treatment organizations in the United States, has appointed two experienced…
Shape Memory Medical Receives ANVISA Authorization for IMPEDE Embolization Plug Portfolio in Brazil Shape Memory Medical Inc., a medical technology company developing volume-expanding shape memory polymer solutions for endovascular embolization, has announced that Brazil’s national health surveillance agency, Agência Nacional…
NeuroLife Appoints Christopher Coburn and Matthew Thomas to Board as Company Advances Neurotechnology Platform Appoints®, a neurotechnology company focused on developing non-invasive solutions to help restore function and independence for people living with stroke and spinal cord injury, has announced…
Argonaut Manufacturing Services Appoints J.D. Mowery to Board of Directors Argonaut Manufacturing Services (Argonaut), a U.S.-based contract development and manufacturing organization (CDMO) specializing in sterile fill-finish services for injectable biologics and pharmaceutical products, has announced the appointment of J.D. Mowery…
Gardner Medical Instruments Receives FDA Class I Registration for Ventubation Airway Management System Gardner Medical Instruments, LLC has announced that it has received U.S. Food and Drug Administration (FDA) Class I registration for its Ventubation™ System, a novel airway management…
VB Spine’s ScolimiR-3D Receives FDA Breakthrough Device Designation for Scoliosis Progression Risk Assessment VB Spine LLC, a privately held spine technology company, announced that the U.S. Food and Drug Administration (FDA) has granted Breakthrough Device Designation to ScolimiR-3D, an in…
Meitheal Pharmaceuticals Announces FDA Approval of High-Concentration Interchangeable YUSIMRY Biosimilar to Humira Meitheal Pharmaceuticals, Inc., a Chicago-based fully integrated biopharmaceutical company focused on the development and commercialization of generic injectables, fertility products, biologics and branded medicines, announced that the U.S.…
Biodextris Appoints Clement Fourny as CEO to Lead Next Phase of Biologics CDMO Growth Biodextris, a Laval, Quebec-based biologics contract development and manufacturing organization (CDMO), has appointed Clement Fourny as its new chief executive officer. The leadership transition comes as…